Negative Symptoms Of Schizophrenia, Hallucinations And Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations And Delusions Associated With Parkinson Disease Psychosis
Phase I
Not Yet Recruiting
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
May 12, 2025
―
Ly03017
Parkinson Disease Psychosis, Negative Symptoms Of Schizophrenia, Alzheimer's Disease Psychosis
Phase I
Not Yet Recruiting
Effect of Food and Age on the Pharmacokinetics of LY03017
Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects
Dec 19, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Luye Pharma Group Ltd. (2186) have in its pipeline
2186 is currently developing the following drugs: Ly03017, Ly03017, Lpm3770164 Sustained Release Tablet Simulant, Lpm3770164 Sustained Release Tablet 5 Mg, Lpm3770164 Sustained Release Tablet 10 Mg, Lpm3770164 Sustained Release Tablet 20 Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.